| Product Name | MF | CAS | Details |
|---|
| Gatifloxacin Impurity 4 | C17H20FN3O4 | 172426-87-8 | Details |
| Metronidazole Impurity 4(Metronidazole EP Impurity D ) | C5H7N3O3 | 5006-68-8 | Details |
| Moxifloxacin Impurity 25 (Mixture of enantiomers) | C21H25ClFN3O4 | 1346603-25-5 | Details |
| Metronidazole Impurity 6(Metronidazole EP Impurity F ) | C8H13N3O4 | 16156-94-8 | Details |
| Moxifloxacin Impurity 30 | C7H14N2 | 158060-81-2 | Details |
| Cefazedone Impurity 4 | C8H8N2O3S | 184696-69-3 | Details |
| Moxifloxacin Impurity 17 | C22H27ClFN3O4 | 1350716-67-4 | Details |
| Mesalazine Impurity 13（Mesalazine EP Impurity M） | C7H4ClNO4 | 2516-96-3 | Details |
| Montelukast Impurity 9（Montelukast EP Impurity I） | C35H36ClNO4S | 2045402-27-3 | Details |
| Moxifloxacin Impurity 29 | C7H14N2 | 169533-55-5 | Details |
| Empagliflozin Impurity 4 | C17H17ClO2 | 2517968-35-1 | Details |
| Gefitinib Impurity 1 | C21H22ClFN4O3 | 847949-49-9 | Details |
| Gefitinib Impurity 8 | C11H10N2O4 | 179688-53-0 | Details |
| Methylprednisolone Impurity 5（Prednisolone Hemisuccinate） | C25H32O8 | 2920-86-7 | Details |
| Montelukast Impurity 2（Montelukast EP Impurity B） | C35H34ClNO2S | 918972-54-0 | Details |
| Gefitinib Impurity 4 | C22H25ClN4O4 | 847949-50-2 | Details |
| Moxifloxacin Impurity 34 (Moxifloxacin EP Impurity H) | C22H26FN3O4 | 721970-35-0 | Details |
| Moxifloxacin Impurity 10（Moxifloxacin EP Impurity E HBr） | C20H23BrFN3O4 | 1292904-74-5 | Details |
| Montelukast Impurity 8（Montelukast EP Impurity H） | C34H32ClNO4S | 851755-56-1 | Details |
| Pemetrexed Impurity 4（Pemetrexed EP Impurity C） | C40H40N10O13 | 1802552-16-4 | Details |
| Gefitinib Impurity 6 | C16H13ClFN3O2 | 153437-78-6 | Details |
| Moxifloxacin Impurity 6 | C20H22ClF2N3O3 | 151282-23-4 | Details |
| Moxifloxacin Impurity 9 | C21H25ClFN3O4 | 2252446-69-6 | Details |
| Upadacitinib Impurity 3 | C7H6O3 | 69-72-7 | Details |
| Thiamphenicol Impurity 1 | C10H15NO4S | 51458-28-7 | Details |
| Moxifloxacin Impurity 21 | C14H16N2O2 | 128740-13-6 | Details |
| Gefitinib Impurity 17 | C16H21N3O4 | 199327-61-2 | Details |
| Gatifloxacin Impurity 1 | C18H20FN3O4 | 616205-76-6 | Details |
| Montelukast Impurity 4（Montelukast EP Impurity D） | C41H46ClNO5S2 | 1187586-61-3 | Details |
| Gatifloxacin Impurity 2 | C13H9F2NO4 | 154093-72-8 | Details |
| Gefitinib Impurity 3 | C20H22ClFN4O3 | 847949-56-8 | Details |
| Macitentan Impurity 1 | C16H13Br2N5O2 | 1433875-21-8 | Details |
| Macitentan Impurity 2 | C10H8Br2N4O2 | 2211054-90-7 | Details |
| Gatifloxacin | C19H22FN3O4 | 112811-59-3 | Details |
| Mesalazine Impurity 10（Mesalazine EP Impurity J） | C7H8N2O3 | 112725-89-0 | Details |
| Moxifloxacin Impurity 26 | C20H25ClFN3O2 | 2664848-61-5 | Details |
| Gefitinib Impurity 2 | C15H11ClFN3O2 | 184475-71-6 | Details |
| Montelukast Impurity 1（Montelukast EP Impurity A） | C35H37ClNNaO3S | 190078-45-6 | Details |
| Moxifloxacin Hydrochloride | C21H25ClFN3O4 | 186826-86-8 | Details |
| Montelukast Impurity 5（Montelukast EP Impurity E） | C41H46ClNO5S2 | 1187586-58-8 | Details |
| L-Ornithine L-Aspartate Impurity 2 | C8H12N2O7 | 60079-22-3 | Details |
| Empagliflozin Impurity 12 | C23H27ClO7 | 2452301-42-5 | Details |
| Gefitinib Impurity 19 | C15H21N3O3 | 675126-27-9 | Details |
| Pemetrexed Impurity 5（Pemetrexed EP Impurity D) | C25H28N6O9 | 144051-68-3 | Details |
| Moxifloxacin Impurity 3 | C17H17F2NO4 | 172602-83-4 | Details |
| Gefitinib Impurity 5 | C29H37ClFN5O4 | 1502829-45-9 | Details |
| Moxifloxacin Impurity 35 | C23H28FN3O4 | 1403836-23-6 | Details |
| Pemetrexed Disodium Salt | C20H22N5NaO6 | 150399-23-8 | Details |
| Milnacipran | C15H23ClN2O | 101152-94-7 | Details |
| Moxifloxacin Impurity 7 | C22H28ClN3O5 | 2252446-68-5 | Details |
| Mesalazine Impurity 21（Mesalazine EP Impurity N） | C7H5NO5 | 96-97-9 | Details |
| Mosapride Impurity 2 | C14H20ClN3O3 | 152013-26-8 | Details |
| Metronidazole Impurity 7(Metronidazole EP Impurity G ) | C6H7N3O4 | 1010-93-1 | Details |
| Moxifloxacin Impurity 15 | C7H14N2 | 147459-51-6 | Details |
| Moxifloxacin Impurity 19 | C16H16F3NO4 | 112811-70-8 | Details |
| Montelukast Impurity 7（Montelukast EP Impurity G） | C35H36ClNO3S | 774538-96-4 | Details |
| Moxifloxacin Impurity 5 | C16H15F2NO4 | 1329836-33-0 | Details |
| Empagliflozin | C23H27ClO7 | 864070-44-0 | Details |
| Pemetrexed Impurity 2（Pemetrexed EP Impurity A） | C21H23N5O6 | 869791-42-4 | Details |
| Mesalazine Impurity 7（Mesalazine EP Impurity G） | C7H6O4 | 490-79-9 | Details |
| Montelukast Impurity 6（Montelukast EP Impurity F） | C34H32ClNO3S | 937275-23-5 | Details |
| Gatifloxacin Impurity 3 | C18H20FN3O4 | 112811-57-1 | Details |
| Moxifloxacin Impurity 27 | C14H13FN2O4 | 172426-88-9 | Details |
| Gefitinib Impurity 11 | C15H23N3O4 | 246512-44-7 | Details |
| Moxifloxacin Impurity 4 | C15H13F2NO4 | 452092-31-8 | Details |
| Gefitinib Impurity 14 | C22H24F2N4O3 | 184475-50-1 | Details |
| Gefitinib Impurity 16 | C22H24ClFN4O3 | 1603814-04-5 | Details |
| Dronedarone Impurity 1（N-Oxide） | C31H44N2O6S | 1638586-56-7 | Details |
| Mesalazine Impurity 20（Mesalazine EP Impurity L） | C7H5ClO2 | 118-91-2 | Details |
| Gefitinib Impurity 10 | C17H13ClFN3O3 | 788136-89-0 | Details |
| Pemetrexed Impurity 6（Pemetrexed EP Impurity E） | C20H21N5O6 | 182009-04-7 | Details |
| Moxifloxacin Impurity 11 | C21H24FN3O4 | 1394029-14-1 | Details |
| Empagliflozin Impurity 2 | C23H27ClO7 | 864070-43-9 | Details |
| Cefradine Impurity 1（Cefradine EP Impurity A） | C8H10N2O3S | 22252-43-3 | Details |
| Milnacipran Impurity 2 | C15H22N2O | 2254103-65-4 | Details |
| Macitentan Impurity 5 | C19H20BrClN6O4S | 2443747-63-3 | Details |
| Moxifloxacin Impurity 23 | C14H10N2O2 | 18184-75-3 | Details |
| Montelukast | C35H37ClNNaO3S | 151767-02-1 | Details |
| Mesalazine Impurity 12 | C7H7NO3 | 1571-72-8 | Details |
| Moxifloxacin Impurity 1 | C15H12F3NO3 | 94242-51-0 | Details |
| Mitiglinide | C19H25NO3 | 145375-43-5 | Details |
| Memantine Impurity 1 | C11H19N | 33103-93-4 | Details |
| Mosapride Impurity 3 | C27H31ClFN3O9 | 1215825-20-9 | Details |
| Mosapride Impurity 1 | C21H25ClFN3O4 | 1161443-73-7 | Details |
| Pemetrexed Impurity 3（Pemetrexed EP Impurity B） | C40H40N10O13 | 1802552-04-0 | Details |
| Empagliflozin Impurity 10 | C17H16BrClO2 | 915095-89-5 | Details |
| Gefitinib Impurity 13 | C22H24ClFN4O4 | 847949-51-3 | Details |
| Montelukast Impurity 10 | C29H26ClNO2 | 1258428-71-5 | Details |
| Mesalazine Impurity 16（Mesalazine EP Impurity P） | C13H11NO6S | 887256-40-8 | Details |
| Empagliflozin Impurity 1 | C23H27ClO7 | 1620758-33-9 | Details |
| Moxifloxacin Impurity 22 | C14H20N2 | 128740-14-7 | Details |
| Moxifloxacin Impurity 33 | C15H16F3NO4 | 121577-35-3 | Details |
| Moxifloxacin Impurity 8 (Moxifloxacin EP Impurity C) | C22H27ClFN3O4 | 2252446-70-9 | Details |
| Topirast impurity 5 | C17H17ClO3 | 2770456-61-4 | Details |
| Montelukast Impurity 3（Montelukast EP Impurity C） | C35H36ClNO4S | 909849-96-3 | Details |
| Mesalazine Impurity 18（Mesalazine EP Impurity R） | C7H5NO5 | 85-38-1 | Details |
| Empagliflozin Impurity 7 | C23H29ClO8 | 1620758-34-0 | Details |
| Empagliflozin Impurity 6 | C23H27ClO7 | 1620758-31-7 | Details |
| Mesalazine Impurity 5（Mesalazine EP Impurity E） | C7H7NO3 | 65-49-6 | Details |
| Empagliflozin Impurity 3 | C25H29ClO8 | 2452301-09-4 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 | ||||